[Reporter¡¯s view] Did they act honorably?
By Kim, Jin-Gu | translator Choi HeeYoung
20.03.04 06:20:15
°¡³ª´Ù¶ó
0
Recently, press releases of this kind have increased in the reporter's mailbox. With the spread of the COVID-19 crisis, many pharmaceutical companies are jumping into the development of drugs or vaccines.
But some do not seem pure intentions. It is obviously expected to float stocks.
For example, Company A is developing a new drug that suppresses Cytokines, claiming it could be used to treat COVID-19. In addition, it added that it applied for an emergency clinical trial plan with the Ministry of Food and Drug Safety.
Company B, which is developing a new antiviral drug, has announced that it has applied fo
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)